STC2 was upregulated in cervical cancer and promoted cervical cancer cell proliferation.
Cisplatin resistant cells had elevated STC2 levels and enhanced proliferation.
STC2 regulated cisplatin chemosensitivity in cervical cancer cells.
STC2 regulated the activity of the MAPK signaling pathway.